| Revenue growth | FY26 up 23%; Q4 up 25.7% YoY. |
|---|---|
| Margins | EBITDA margin steady at 20-21%; PAT margin 21.5% in Q4. |
| Demand visibility | Strong domestic demand; 50% market share in India. |
| Management confidence | High; confident in sustaining 20-21% margins despite volatility. |
Growth
FY26 operating revenue grew 23% to ₹215.45 Cr; PAT grew 18% to ₹50.27 Cr. Q4 FY26 revenue up 25.7% YoY.
Outlook
Revenue guidance of ₹250 Cr+ for FY27. CAPEX plans for Boron Oxide capacity (4,000 MTPA) and forward integration.
Risks
Geopolitical volatility affecting raw material costs; concentration of boron ore supply in Turkey and Americas.
Earnings Call filed with NSE, NSE: INDOBORAX. Summary written with AI assistance from the document.
Indo Borax & Chemicals Ltd: key numbers
- Share price
- ₹480.90
- Market cap
- ₹1,543 Cr
- Revenue (annual)
- ₹215.4 Cr
- Net profit (annual)
- ₹50.27 Cr
- P/E (TTM)
- 27.4×Sector 36.8×
- Promoter holding
- 38.41%+7.61% QoQ
- FII holding
- 0.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo Borax & Chemicals Ltd
All →Indo Borax & Chemicals Debt & Borrowing: ₹225 Cr
Indo Borax & Chemicals Ltd has availed funding of ₹225 Crore from a lending institution. The capital will finance its acquisition of equity shares in Kronox Lab Sciences Limited.
- Value
- ₹225.0 Cr
Indo Borax & Chemicals Annual General Meeting
Indo Borax & Chemicals reported postal ballot results where shareholders approved borrowing limits up to Rs 400 Crore. One special resolution passed with 98.05% in favour.
Indo Borax & Chemicals Earnings Call Transcript: Key Takeaways
Indo Borax reported robust Q1 FY27 results with 31% revenue growth and 59% PAT growth. Management announced a major acquisition of 64.26% stake in Kronox Lab Sciences to diversify into high-purity specialty chemicals.
- Call
- Guides 19% growth
Indo Borax & Chemicals Investor Presentation: Key Takeaways
Indo Borax reported strong Q1FY27 consolidated performance with Revenue up 31% and PAT up 59% YoY. Strategy focuses on high-margin DOT expansion and the acquisition of Kronox Lab Sciences.
Indo Borax & Chemicals Credit Rating
Indo Borax & Chemicals Ltd received a credit rating update from India Ratings, placing its bank loan facilities on 'Rating Watch with Negative Implications'.
Indo Borax & Chemicals Other Announcement
Indo Borax & Chemicals Ltd. is relocating its corporate office to a new premises in Andheri (East), Mumbai, effective September 15, 2026.